Antibodies to the RBD of SARS-CoV-2 spike mediate productive infection of primary human macrophages

S Pickering, H Wilson, E Bravo, MR Perera… - Nature …, 2024 - nature.com
The role of myeloid cells in the pathogenesis of SARS-CoV-2 is well established, in
particular as drivers of cytokine production and systemic inflammation characteristic of …

Proteomics validate circulating GDF-15 as an independent biomarker for COVID-19 severity

S Bu, L Royston, T Mabanga, CA Berini… - Frontiers in …, 2024 - frontiersin.org
Introduction Growth differentiation factor 15 (GDF-15) was originally described as a stress-
induced cytokine, and a biomarker of aging and cardiovascular diseases. We hypothesized …

Proteomic characterization of acute kidney injury in patients hospitalized with SARS-CoV2 infection

I Paranjpe, P Jayaraman, CY Su, S Zhou… - Communications …, 2023 - nature.com
Background Acute kidney injury (AKI) is a known complication of COVID-19 and is
associated with an increased risk of in-hospital mortality. Unbiased proteomics using …

[HTML][HTML] Impact and prevalence of comorbidities and complications on the severity of COVID-19 in association with age, gender, obesity, and pre-existing smoking: A …

S Djorwé, A Bousfiha, N Nzoyikorera, J Nyandwi… - BioMedicine, 2024 - ncbi.nlm.nih.gov
Background COVID-19 patients usually present multiple comorbidities and complications
associated with severe forms of SARS-CoV-2 infection. This study aimed to assess the risk …

Proteomic signatures of vaccine-induced and breakthrough infection-induced host responses to SARS-CoV-2

E Williams, FE Tribin, JM Carreño, F Krammer, M Hoffer… - Vaccine, 2025 - Elsevier
The severity of SARS-CoV-2 illness is influenced by factors including age, sex, pre-existing
health conditions, and individual immune responses. However, the mechanisms conferring …

Multi-omics identify LRRC15 as a COVID-19 severity predictor and persistent pro-thrombotic signals in convalescence

JS Gisby, NB Buang, A Papadaki, CL Clarke, TH Malik… - medRxiv, 2022 - medrxiv.org
Patients with end-stage kidney disease (ESKD) are at high risk of severe COVID-19. Here,
we performed longitudinal blood sampling of ESKD haemodialysis patients with COVID-19 …

Multi-ancestry proteome-phenome-wide Mendelian randomization offers a comprehensive protein-disease atlas and potential therapeutic targets

CY Su, A van der Graaf, W Zhang, DK Jang… - medRxiv, 2024 - medrxiv.org
Circulating proteins influence disease risk and are valuable drug targets. To enhance the
discovery of protein-phenotype associations and identify potential therapeutic targets across …

Longitudinal analysis of the lung proteome reveals persistent repair months after mild to moderate COVID-19

SM Kanth, JA Huapaya, S Gairhe, H Wang, X Tian… - Cell Reports …, 2024 - cell.com
In order to assess homeostatic mechanisms in the lung after COVID-19, changes in the
protein signature of bronchoalveolar lavage from 45 patients with mild to moderate disease …

[PDF][PDF] Proteomic characterization of acute kidney injury in patients hospitalized with SARS-CoV2 infection

AW Charney, GN Nadkarni - d-nb.info
Background Acute kidney injury (AKI) is a known complication of COVID-19 and is
associated with an increased risk of in-hospital mortality. Unbiased proteomics using …

[HTML][HTML] Proteomic Characterization of Acute Kidney Injury in Patients Hospitalized with SARS-CoV2 Infection

G Nadkami, I Paranjpe, P Jayaraman, CY Su… - Research …, 2023 - ncbi.nlm.nih.gov
Background Acute kidney injury (AKI) is a known complication of COVID-19 and is
associated with an increased risk of in-hospital mortality. Unbiased proteomics using …